Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control

Nausea Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01527890
• Other study ID #: 3-2011-0238
• Status: Recruiting
• Phase: N/A
• First received: January 27, 2012
• Last updated: February 2, 2012
• Start date: February 2012
• Est. completion date: October 2012

Study information

• Verified date: February 2012
• Source: Yonsei University
• Contact: Yon Hee Shim, MD, PhD
• Phone: 82-2-2019-3547
• Email: tren125[@]yuhs.ac
• Is FDA regulated: No
• Health authority: Korea: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

In this retrospective study, the investigators examined incidence and risk factors of postoperative nausea and vomiting (PONV) in patients with fentanyl-based intravenous patient-controlled analgesia (IV-PCA).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: October 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Adults between 20 to 60 years old

2. Date from 1st, May 2011 to 31st, October 2011

3. Patients with fentanyl based intravenous patient-controlled analgesia for postoperative pain control

Exclusion Criteria:

1. Reoperation within 48 hours

2. Patients who cannot express numerical rating scale for pain due to sedation

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Nausea
• Vomiting

Intervention

Drug:
• Fentanyl
intravenous patient-controlled analgesia

Locations

Country	Name	City	State
Korea, Republic of	Gangnam Severance Hospital	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of,